Signature Cells: High-potency cells for more effective treatment
A global leader
Backed by 22 years of clinically based research.
Our medical experts have studied at top institutions – with advanced degrees and collectively overseen thousands of stem cell transplants.
Industry-leading allogeneic Wharton jelly
mesenchymal stem cells derived from umbilical cord (WJ-MSC) with high immunomodulatory potential and cytokine secretion.
Advanced treatment protocols
Proprietary protocols offering millions of cells
are personalized for each patient for best possible outcome - based on each patient’s unique conditions.
Real people. Real results.
How cell therapy can change your life
Advanced Treatments and Therapies
A global leader in cell therapy and research
Backed by 22 years of clinically based cell science and research, BioXcellerator has successfully treated patients for sports and orthopedic injuries, spine and disc conditions, and other disorders.
Our scientists and physicians have also developed advanced immunomodulatory and anti-inflammatory treatments, designed to improve your health, modulate your immune system, and potentially help you live a longer, more active life.
Our proprietary protocols for administering allogeneic Wharton jelly mesenchymal stem cells derived from umbilical cord (WJ-MSC) are personalized for each patient for the best possible success.
High-potency cells for more effective treatment
Our advanced protocols include a rigorous selection process to culture highly potent MSC. These cells from Wharton’s Jelly from donated umbilical cords are carefully screened and purified to ensure you receive infusions of millions of high-quality cells with:
High levels of anti-inflammatory properties
Best potential to modulate your immune system
More potential to stimulate healing
Signature Cells Process helps create high-potency cells that work more quickly and effectively to promote healing, reduce inflammation, and regenerate damaged tissues.
Why Patients Choose BioXcellerator - A Global Clinic of Choice
Discover how cell therapy can improve
the quality of your life
For more details, call one of our dedicated Patient Advocates
at 1-888-567-2469 or complete the form below:
The fundamentals of the BioXcellerator quality management system are based on the following regulations and standards for cell therapy, safety and infrastructure conditions:
CAT Standards for the Obtention, Processing, Storage and Distribution of Blood Umbilical cord.
INVIMA (the institution that fulfills the role of the FDA in Colombia) Standards: Good Practices for Tissue Banks and Bone Marrow.
FACT-JACIE International standards for the collection, processing and administration of hematopoietic cell therapy products.
ISO 14644: 2016 Standard Air quality in controlled environments.
ISO 9001: 2015 Standard Quality Management Systems.
Colombian resolution 2378 of 2008 Adoption of Good Clinical Practices for Research with Medicines in Humans (specifically for clinical research projects).
ASS-RSA-GU045 Clinical Investigation Medicine and Supplies Guide INVIMA.
ISSCR International Society for Stem Cell Research.
GMP Spanish Agency of Medicines and Health Products.
Enabling Standards under Colombian Resolution 2003 of 2014.